神经药理学报

• 专题论著 •上一篇下一篇

焦虑抑郁共病障碍的研究进展

梁慧,程涛,梁建辉

  1. 1. 北京大学基础医学院药理学系,北京,100083,中国
    2. 北京大学药学院分子与细胞药理学系,北京,100083,中国
  • 出版日期:2017-12-26发布日期:2017-12-01
  • 通讯作者:梁建辉,男,博士,研究员,博士生导师;研究方向:神经精神药理学;Tel:+86-010-82802452,Fax:+86-010-62032624,E-mail:liangjh@bjmu.edu.cn
  • 作者简介:梁慧,女,硕士研究生;研究方向:神经精神药理学;E-mail:sophia_lh@sina.cn
  • 基金资助:
    国家自然科学基金项目(No.81773705)

Progress in the Comorbidity of Depression and Anxiety

LIANG Hui,CHENG Tao,LIANG Jian-hui

  1. 1. Department of Pharmacology,Peking University School of Basic Medical Science,Beijing,100083,China
    2. Department of Molecular and Cellular Pharmacology,Peking University School of Pharmaceutical Sciences,Beijing,100083,China
  • Online:2017-12-26Published:2017-12-01
  • Contact:梁建辉,男,博士,研究员,博士生导师;研究方向:神经精神药理学;Tel:+86-010-82802452,Fax:+86-010-62032624,E-mail:liangjh@bjmu.edu.cn
  • About author:梁慧,女,硕士研究生;研究方向:神经精神药理学;E-mail:sophia_lh@sina.cn
  • Supported by:
    国家自然科学基金项目(No.81773705)

摘要:

传统观点将焦虑障碍和抑郁障碍视为两个独立的疾病单元,然而,在临床实践和流行病学调查中,焦虑抑郁共病的发病率高,且预后差。该文介绍了共病障碍的基本概念,共病特点,治疗措施以及相关的动物模型,着重讨论新的动物模型的建立和新型抗焦虑和抗抑郁双重治疗药物的开发对焦虑和抑郁共病障碍诊断、治疗和预防的积极意义。

关键词:焦虑,抑郁,共患病,动物模型

Abstract:

It is traditionally thought that anxiety disorder and depressive disorder are categorically defined as two individual psychiatric disorders. As clinical practice and epidemiological studies show,however,the comorbidity of depression and anxiety is prevalent and of poorer outcomes than either disorder alone. In this review,the concepts,clinical features,therapeutic managements,and animal models related to the comorbidity of depression and anxiety are well addressed. In addition,establishing the novel animal models and developing the new agents of both anti-depression and-anxiety are discussed to improve its diagnosis,treatment,and medical prevention.

Key words:anxiety,depression,comorbidity,animal model

中图分类号:

Baidu
map